Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

EGRXEGRX
19 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in EAGLE PHARMACEUTICALS INC

PRICE T ROWE ASSOCIATES INC /MD/ previously held 0 shares of EGRX (EAGLE PHARMACEUTICALS INC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$864,000

Total Shares Change

-15,272

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Unchanged
13,300
0.0%
$50,0000.0%$3.95
0
2024-Q2
Decreased
13,300
-15.5%
$75,0000.0%$5.60
0
2024-Q1
New
15,748
-
$83,0000.0%$5.24
33
2023-Q1
Exited
0
-100.0%
$00.0%$27.88
0
2022-Q4
Increased
15,893
+6.8%
$465,0000.0%$29.23
26
2022-Q3
Increased
14,875
+54.2%
$393,0000.0%$28.60
33
2022-Q2
Decreased
9,644
-26.3%
$428,0000.0%$43.12
0
2022-Q1
Decreased
13,088
-1.4%
$648,0000.0%$49.50
0
2021-Q4
Decreased
13,267
-1.5%
$676,0000.0%$51.10
0
2021-Q3
Decreased
13,475
-0.1%
$752,0000.0%$55.09
0
2021-Q2
Decreased
13,485
-10.3%
$577,0000.0%$42.14
0
2021-Q1
Decreased
15,039
-24.2%
$628,0000.0%$41.06
0
2020-Q4
Decreased
19,840
-23.5%
$924,0000.0%$46.50
0
2020-Q3
Increased
25,943
+38.1%
$1.1M0.0%$41.88
33
2020-Q2
Decreased
18,787
-7.2%
$901,0000.0%$48.02
0
2020-Q1
Increased
20,236
+28.3%
$931,0000.0%$45.31
31
2019-Q4
Increased
15,772
+3.3%
$948,0000.0%$59.89
26
2019-Q3
First report
15,272
-
$864,0000.0%$56.43
0

Other major holders of EGRX: BNP PARIBAS FINANCIAL MARKETS, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used